文献速递骨质疏松与钙磷/甲状旁腺

内源性分泌型晚期糖基化终产物受体与戊糖苷比值可预测男性骨折

Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

在1285名≥65岁日本男性中开展为期5年的前瞻性队列研究,基线检测血清esRAGE、戊糖苷(PEN)及esRAGE/PEN比值并测量骨密度,随访25例发生临床脆性骨折。校正年龄、糖化血红蛋白及骨密度后,esRAGE/PEN比值升高与脆性骨折风险降低相关,且独立于骨密度。

要点

  • esRAGE/PEN比值每升高1个标准差,脆性骨折风险降低(校正后HR 0.64–0.67)。
  • PEN每升高1个标准差,骨折风险升高,但额外校正HbA1c后显著性减弱。
  • esRAGE与骨折风险无显著关联(粗HR 0.79,95%CI 0.54–1.15)。

核心结论

  • 较高的esRAGE/PEN比值与老年日本男性脆性骨折风险降低相关,且独立于骨密度。

研究设计与样本

  • 前瞻性队列研究,纳入1285名≥65岁日本男性,来自2007至2008年Fujiwara-kyo骨质疏松风险男性研究基线调查,随访5年。

主要发现

  • 25名男性发生临床脆性骨折。
  • PEN、esRAGE、esRAGE/PEN比值的粗HR(95%CI)分别为1.56(1.05–2.31)、0.79(0.54–1.15)、0.65(0.44–0.95)。
  • PEN校正年龄、esRAGE及股骨颈骨密度T值后HR为1.48(1.00–2.18),校正腰椎骨密度T值后HR为1.51(1.03–2.21)。
  • 额外校正糖化血红蛋白后,股骨颈骨密度校正模型的显著性为边缘性(P=0.111),腰椎骨密度校正模型的统计学显著性减弱(P=0.072)。
  • esRAGE/PEN比值校正年龄、糖化血红蛋白及股骨颈和腰椎骨密度T值后HR分别为0.67(0.45–0.98)和0.64(0.43–0.95)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Although the endogenous secretory receptor for advanced glycation end products (esRAGE) has been associated with reduced activity of pentosidine (PEN), the association between PEN, esRAGE, and fracture is poorly understood. OBJECTIVES: To evaluate the ability of serum PEN and esRAGE levels to predict fragility fractures. METHODS: A cohort of 1285 Japanese men aged ≥65 years old participated in a 2007 to 2008 Fujiwara-kyo Osteoporosis Risk in Men study baseline survey, as part of the Fujiwara-kyo prospective cohort study. Those participants provided information regarding any fractures they experienced during 5 years. The baseline bone mineral density (BMD) was measured. Hazard ratios (HRs) per one standard deviation increase of log-transformed serum levels of PEN, esRAGE, and esRAGE-to-PEN ratio were estimated at baseline. RESULTS: Twenty-five participating men suffered incident clinical fragility fractures. The crude HRs (95% confidence interval) for PEN, esRAGE, and esRAGE-to-PEN ratio were 1.56 (1.05 to 2.31), 0.79 (0.54 to 1.15), and 0.65 (0.44 to 0.95), respectively. HRs for PEN adjusted for age, esRAGE, and T score of BMD at femoral neck (FN) and lumbar spine (LS) were 1.48 (1.00 to 2.18) and 1.51 (1.03 to 2.21), respectively. The marginal significance adjusted for BMD at FN and the statistical significance adjusted for BMD at LS were attenuated after additional adjustment for glycated hemoglobin A1c level (P = 0.111 and 0.072, respectively). The HRs for esRAGE-to-PEN ratio adjusted for age, glycated hemoglobin A1c, and T-score of BMD at FN and LS were 0.67 (0.45 to 0.98) and 0.64 (0.43 to 0.95). CONCLUSIONS: Higher esRAGE-to-PEN ratios were associated with decreased risk of fragility fractures independent of BMD among elderly Japanese men.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tamaki J, Kouda K, Fujita Y, et al. Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men. J Clin Endocrinol Metab. 2018. PMID: 29040721. doi:10.1210/jc.2017-00929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。